Bastiaan van der Baan
Algemeen Directeur bij LIXTE BIOTECHNOLOGY HOLDINGS, INC.
Vermogen: 35 420 $ op 30-04-2024
Actieve functies van Bastiaan van der Baan
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
LIXTE BIOTECHNOLOGY HOLDINGS, INC. | Voorzitter | 17-06-2022 | - |
Algemeen Directeur | 26-09-2023 | - | |
President | 26-09-2023 | - | |
Directeur/Bestuurslid | 17-06-2022 | 06-10-2023 | |
Independent Dir/Board Member | 17-06-2022 | 26-09-2023 | |
Tethis SpA
Tethis SpA BiotechnologyHealth Technology Tethis SpA engages in the provision of nanobiotechnology solutions. It develops devices for liquid biopsy, molecular diagnostic, and proteomic and microbiology. The company was founded by Emanuele Barborini, Simone Vinati, and Massimo Gatelli in 2004 and is headquartered in Milan Italy. | Directeur/Bestuurslid | 19-07-2021 | - |
Independent Dir/Board Member | 19-07-2021 | - | |
Xgen Venture Sgr SpA
Xgen Venture Sgr SpA Investment ManagersFinance Xgen Venture Sgr SpA (XGEN Venture) is a venture capital firm founded in 2021 by Federica Draghi, Paolo Fundarò and Daniele Scarinci. The firm is headquartered in Milan, Italy. | Private Equity Investor | 01-01-2023 | - |
Loopbaan van Bastiaan van der Baan
Eerdere bekende functies van Bastiaan van der Baan
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Agendia, Inc.
Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA. | Corporate Officer/Principal | 01-07-2012 | 01-07-2023 |
Verkoop & Marketing | 01-07-2012 | 01-07-2023 | |
thromboDx BV | Oprichter | 01-09-2011 | 01-01-2016 |
UNILEVER PLC | Verkoop & Marketing | - | - |
Agendia NV
Agendia NV Medical/Nursing ServicesHealth Services Agendia NV discovers and develops products for clinical management of cancer. It operates as a commercial-stage molecular diagnostic company that focuses on the discovery, development, and commercialization of products to improve the quality of life for cancer patients. The company was founded by Rene Bernards and Laura van't Veer in 2003 and is headquartered in Amsterdam, the Netherlands. | Corporate Officer/Principal | - | - |
Opleiding van Bastiaan van der Baan
Wageningen University | Graduate Degree |
Statistieken
Internationaal
Nederland | 4 |
Verenigde Staten | 3 |
Italië | 3 |
Operationeel
Corporate Officer/Principal | 2 |
Sales & Marketing | 2 |
Director/Board Member | 2 |
Sectoraal
Health Technology | 4 |
Health Services | 2 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
UNILEVER PLC | Consumer Non-Durables |
LIXTE BIOTECHNOLOGY HOLDINGS, INC. | Health Technology |
Bedrijven in privébezit | 5 |
---|---|
Agendia, Inc.
Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA. | Health Technology |
Agendia NV
Agendia NV Medical/Nursing ServicesHealth Services Agendia NV discovers and develops products for clinical management of cancer. It operates as a commercial-stage molecular diagnostic company that focuses on the discovery, development, and commercialization of products to improve the quality of life for cancer patients. The company was founded by Rene Bernards and Laura van't Veer in 2003 and is headquartered in Amsterdam, the Netherlands. | Health Services |
Tethis SpA
Tethis SpA BiotechnologyHealth Technology Tethis SpA engages in the provision of nanobiotechnology solutions. It develops devices for liquid biopsy, molecular diagnostic, and proteomic and microbiology. The company was founded by Emanuele Barborini, Simone Vinati, and Massimo Gatelli in 2004 and is headquartered in Milan Italy. | Health Technology |
thromboDx BV | |
Xgen Venture Sgr SpA
Xgen Venture Sgr SpA Investment ManagersFinance Xgen Venture Sgr SpA (XGEN Venture) is a venture capital firm founded in 2021 by Federica Draghi, Paolo Fundarò and Daniele Scarinci. The firm is headquartered in Milan, Italy. | Finance |